AsclepiX Therapeutics
AsclepiX Therapeutics is a startup headquartered in Bethesda, United States, founded in 2023. It has raised at least $10.0m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
AsclepiX Therapeutics has raised at least $10.0m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
AsclepiX Therapeutics sits inside the Washington DC and Maryland R&D ecosystem in the Global R&D Labs Directory.
Other startups in Bethesda
- Accompany Health
- Authmind
- Centile Bioscience
- Emerald Intelligence
- Heeler Security
- MedVanta
- PicassoMD
- Solaxa
- VerImmune
Related
- Innovation profile of Bethesda
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does AsclepiX Therapeutics do?
AsclepiX Therapeutics is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has AsclepiX Therapeutics raised?
At least $10.0m, according to its Form D filings with the US Securities and Exchange Commission.
Where is AsclepiX Therapeutics based?
AsclepiX Therapeutics is headquartered in Bethesda, United States.
When was AsclepiX Therapeutics founded?
AsclepiX Therapeutics was founded in 2023.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.